Cancer immunotherapy Authors Stefano Vella Direttore, Dipartimento del Farmaco, Istituto Superiore di Sanità, Roma - Italy DOI: https://doi.org/10.33393/grhta.2016.305 Keywords: Immunoterapia, Cancer Abstract No abstract
Downloads PDF (Italian) ePub How to Cite Vella, S. (2019). Cancer immunotherapy. Global and Regional Health Technology Assessment, 3(Suppl. 1), S1-S2. https://doi.org/10.33393/grhta.2016.305 More Citation Formats ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver Download Citation Endnote/Zotero/Mendeley (RIS) BibTeX Issue Vol. 3 No. Suppl. 1 (2016): Suppl. 1 - Farmaci oncologici e sostenibilità Section Editorial (on invitation only) License Copyright (c) 2019 The authors This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. Metrics Statistics Abstract views - 788 times PDF (Italian) downloads - 661 times ePub downloads - 337 times Sign up Browse Sections Health Technology Assessment Health Policies banners150 0.8 2023CiteScore 28th percentile Powered by Completed peer reviews since:November 4, 2020 Most popular articles in the last 30 days More and earlier data from AIFA: do they impact on the regional policies? Results from an exploratory analysis 577 The societal costs associated with patients with chronic spontaneous urticaria (CSU) in Italy 385 Non-profit research: an insight into the management and monitoring of clinical trials in Italy 203 Optimising pediatric paracetamol and ibuprofen use: a retrospective study with expert evaluation of efficacy, safety, and healthcare costs 183 Cost minimization analysis of subcutaneous and intravenous immunoglobulin treatment in Italy 172